fulvestrant
Not Tagged
['breast']
sonia trial reveals: cdk 4/6 inhibitor use as either 1st or 2nd line treatment for hr+ her2 metastatic breast cancer has no effect on pfs, overall survival, or qol. this raises the question: is first-line usage of cdk 4/6 inhibitors necessary? #asco23 #oncoalert #qualityoflife 
NCI-designated Univ of Hawai’i Cancer Ctr @UHCancerCenter, Director. Breast Med Oncologist. IBC. Tumor Microenvironment. Japanese Twitter @nuenojpn.